Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Inzucchi: Insulin-sensitizing antihyperglycemic drugs and mortality after acute myocardial.... (0.11 sec) 

Insulin-sensitizing antihyperglycemic drugs and mortality after acute myocardial …

- diabetesjournals.org
SE Inzucchi, FA Masoudi, Y Wang, M Kosiborod, … - Diabetes Care, 2005 - Am Diabetes Assoc
RESEARCH DESIGN AND METHODS—We conducted a retrospective cohort study of 24,953
Medicare beneficiaries with diabetes discharged after hospitalization with AMI between April
1998 and March 1999 or July 2000 and June 2001. The independent association ...
Cited by 55 - Related articles - BL Direct - All 5 versions

Thiazolidinediones, metformin, and outcomes in older patients with diabetes and …

- ahajournals.org
FA Masoudi, SE Inzucchi, Y Wang, EP Havranek, JAM … - Circulation, 2005 - Am Heart Assoc
Methods and Results— We conducted a retrospective cohort study of 16 417 Medicare beneficiaries
with diabetes discharged after hospitalization with the principal discharge diagnosis of heart
failure. The association between antidiabetic drug prescriptions and outcomes was ...
Cited by 195 - Related articles - All 10 versions

Risk of Hospitalization for Heart Failure Associated with Thiazolidinedione Therapy …


DM Hartung, DR Touchette, NC Bultemeier, DG Haxby - Pharmacotherapy, 2005 - PPI
Thiazolidinediones are distinctive among oral antihyperglycemic agents for treatment of type
2 diabetes mellitus in that they exert their pharmacologic effect primarily by improving peripheral
insulin sensitivity through effects on adipose tissue, skeletal muscle, and the liver. In ...
Cited by 23 - Related articles - BL Direct - All 4 versions

Insulin-treated diabetes is associated with a marked increase in mortality in …


S Smooke, TB Horwich, GC Fonarow - American Heart Journal, 2005 - Elsevier
There were 132 patients (23.8%) with diabetes; 43 patients (7.8%) were insulin treated and 89
patients (16.1%) were non–insulin-treated patients with diabetes. The groups were similar in
sex, smoking history, medication profile, ejection fraction, body mass index, and serum ...
Cited by 65 - Related articles - All 13 versions

Pioglitazone initiation and subsequent hospitalization for congestive heart failure


AJ Karter, AT Ahmed, J Liu, HH Moffet, MM … - Diabetic …, 2005 - interscience.wiley.com
Methods A cohort study of all patients in the Kaiser Permanente Medical Care Program with Type
2 diabetes (Kaiser Permanente Northern California Diabetes Registry) who initiated any diabetes
pharmacotherapy (n = 23 440) between October 1999 and November 2001. Only patients ...
Cited by 69 - Related articles - BL Direct - All 4 versions

Metformin and heart failure


SE Inzucchi - Diabetes Care, 2005 - Am Diabetes Assoc
Throughout the world and for many years, metformin has been a mainstay of therapy for patients
with type 2 diabetes. This highly effective and usually well-tolerated oral agent is, to date, the
only one demonstrated to reduce cardiovascular disease (CVD) complications in newly ...
Cited by 35 - Related articles - BL Direct - All 7 versions

Thiazolidinediones and congestive heart failure-exacerbation or new onset of left …


PM Srivastava, P Calafiore, RJ MacIsaac, DL Hare, … - Diabetic …, 2004 - pt.wkhealth.com
Background: Patients with diabetes mellitus have a high incidence of coronary heart disease
and congestive heart failure (CHF). Thiazolidinediones (TZD) are a new class of pharmacological
agents for the treatment of Type 2 diabetes mellitus, which have many beneficial ...
Cited by 17 - Related articles - BL Direct - All 7 versions

Association between congestive heart failure and hospitalization in patients with …


R Rajagopalan, RS Rosenson, AW Fernandes, M Khan … - Clinical therapeutics, 2004 - Elsevier
Patients with type 2 diabetes aged ≥18 years who had begun treatment with pioglitazone or
insulin between January 1999 and December 2001 were identified using the PharMetrics
Patient-Centric database. The sample was restricted to patients for whom there were ≥12 ...
Cited by 33 - Related articles - All 3 versions

Thiazolidinediones and the risk of edema: a meta-analysis


HD Berlie, JS Kalus, LA Jaber - Diabetes research and clinical practice, 2007 - Elsevier
The use of thiazolidinediones (TZDs) in the management of type 2 diabetes mellitus (T2DM)
has been associated with an increased risk of peripheral edema. A meta-analysis was performed
to assess the overall risk for developing edema secondary to TZD. A systematic literature ...
Cited by 34 - Related articles - All 10 versions

Insulin sensitizing pharmacotherapy for prevention of myocardial infarction in …


WH Sauer, AR Cappola, JA Berlin, SE Kimmel - The American journal of …, 2006 - Elsevier
Type 2 diabetes mellitus and insulin resistance are associated with an increased risk of myocardial
infarction (MI). Although differences exist in insulin sensitization among oral hypoglycemic
drugs, it is unclear whether these differences translate into a differential risk of MI and ...
Cited by 19 - Related articles - All 5 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google